Basal gangliar dopaminergic neurons contribute importantly to the sensorimotor information processing of humans and animals, with abnormalities at these synapses leading to disorders such as parkinsonism and tardive dyskinesias. The importance of the dopaminergic innervation to the striatum (caudate and putamen) has been widely recognized. Dopamine released in the striatum acts by means of postsynaptic D 2 and D 1 dopamine receptor subtypes, the D 2 effects appearing to be of principle importance. The current proposal is directed toward the understanding of a less well-recognized, but perhaps equally critical, role for dopamine released in the substantia nigra pars reticulata. This zone of the substantia nigra receives the primary efference of the caudate-putamen (through striatonigral fibers), and current evidence suggests that D 1 receptors are associated with the striatonigral axon terminals. Dopamine's action in this region, therefore, could powerfully influence the output of the basal ganglia. The experiments investigate the properties of D1 (and D2 receptors) in the substantia nigra. Light microscopic localization work is proposed to determine the extent to which each receptor subtypes is associated with pars compacta and/or pars reticulata. To gain further evidence concerning localization of these receptor subtypes injection of the microtubule poison colchicine will be made along the axons, and the transport of D, and D, receptors along mesostriatal and striatonigral axons will be investigated. The functional influences of dopamine's action within substantia nigra will be determined by injecting agonists of D1 and D2 receptors into the substantia nigra of one hemisphere of awake animals ana observing effects on motor function (rotation). Also, using [14 C]2-deoxyglucose autoradiography to chart the influences on basal gangliar metabolism, the effects of dopamine D 1 and D 2 agonists in the substantia nigra will be compared.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS022698-05
Application #
3405494
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1985-09-09
Project End
1992-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
O'Dell, S J; Gross, N B; Fricks, A N et al. (2007) Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience 144:1141-51
Trevitt, Jennifer T; Morrow, Joseph; Marshall, John F (2005) Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation. Brain Res 1035:41-50
Billings, Lauren M; Marshall, John F (2004) Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus. J Neurosci 24:3094-103
Hoover, Brian R; Marshall, John F (2004) Molecular, chemical, and anatomical characterization of globus pallidus dopamine D2 receptor mRNA-containing neurons. Synapse 52:100-13
Billings, Lauren M; Marshall, John F (2003) D2 antagonist-induced c-fos in an identified subpopulation of globus pallidus neurons by a direct intrapallidal action. Brain Res 964:237-43
Hoover, B R; Marshall, J F (2002) Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus. Neuroscience 111:111-25
Marshall, J F; Henry, B L; Billings, L M et al. (2001) The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Neuroscience 105:365-78
Schuller, J J; Marshall, J F (2000) Acute immediate-early gene response to 6-hydroxydopamine infusions into the medial forebrain bundle. Neuroscience 96:51-8
McPherson, R J; Marshall, J F (2000) Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. Synapse 36:194-204
LaHoste, G J; Henry, B L; Marshall, J F (2000) Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666-71

Showing the most recent 10 out of 56 publications